Autor(es): Menegali, Bruno Thizon ; Schuelter-Trevisol, Fabiana ; Barbosa, Alexandre Naime ; Izidoro, Talita Menegali ; Feurschuette, Otto Henrique May ; Marcon, Chaiana Esmeraldino Mendes ; Trevisol, Daisson José
Data: 2022
Identificador Persistente: http://hdl.handle.net/11449/222960
Origem: Oasisbr
Assunto(s): Coronavirus infections; Immunization passive; Vaccine
Made available in DSpace on 2022-04-28T19:47:46Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01
The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.
Universidade do Sul de Santa Catarina Programa de Pós-Graduação em Ciências da Saúde
Universidade do Sul de Santa Catarina Faculdade de Medicina
Universidade do Estado de São Paulo Departamento de Doenças Infecciosas
